The Lancet. OncologyHumansFemaleBreast NeoplasmsRetrospective StudiesNeoadjuvant Therapy
Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an international, retrospective cohort study.
Giacomo Montagna, Michael Alvarado, Sara Myers, Mary M Mrdutt, Susie X Sun, Varadan Sevilimedu, Andrea V Barrio, Astrid Botty van den Bruele, Judy C Boughey, Marissa K Boyle, Angelena Crown, Susan B Kesmodel, Tari A King, Henry M Kuerer, Elmore C Leisha
Published: 202610.1016/S1470-2045(25)00598-4
Abstract
BACKGROUND: Despite the paucity of outcome data, axillary lymph node dissection (ALND) is increasingly being omitted in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy, particularly in those with low-volume residual disease…
Preview only. Read the full abstract at the source